Virtus LifeSci Biotech Products ETF (BBP) Institutional Ownership $66.08 +1.70 (+2.65%) As of 10:17 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Institutional Ownership Changes (13F Filings) for Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP)Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$684.20KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$28.51K Get BBP Insider Trade Alerts Want to know when executives and insiders are buying or selling Virtus LifeSci Biotech Products ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Virtus LifeSci Biotech Products ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/13/2025Flow Traders U.S. LLC7,403$431K0.0%N/A1.851% 2/6/2025 Jag Capital Management LLC3,553$213K0.0%-11.8%1.015% 11/4/2024 Jag Capital Management LLC4,028$253K0.0%N/A1.151% 3/6/2023OLD Mission Capital LLC550$27K0.0%N/A0.157% (Data available from 1/1/2016 forward) BBP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BBP shares? During the previous two years, the following institutional investors and hedge funds held shares of Virtus LifeSci Biotech Products ETF shares: Flow Traders U.S. LLC ($431K), Jag Capital Management LLC ($213K).Learn more on Virtus LifeSci Biotech Products ETF's institutional investors. Which institutional investors have been buying Virtus LifeSci Biotech Products ETF's stock? The following institutional investors have purchased Virtus LifeSci Biotech Products ETF's stock in the last 24 months: Flow Traders U.S. LLC ($7.40K), and Jag Capital Management LLC ($4.03K). How much institutional buying is happening at Virtus LifeSci Biotech Products ETF? Institutional investors have bought a total of 11,431 shares in the last 24 months. This purchase volume represents approximately $684.20K in transactions. Which of Virtus LifeSci Biotech Products ETF's major shareholders have been selling company stock? The following institutional investors have sold Virtus LifeSci Biotech Products ETF stock in the last 24 months: Jag Capital Management LLC ($475.00). How much institutional selling is happening at Virtus LifeSci Biotech Products ETF? Institutional investors have sold a total of 475 shares in the last 24 months. This volume of shares sold represents approximately $28.51K in transactions. Related Companies Goldman Sachs Future Health Care Equity ETF Institutional Ownership Harbor Health Care ETF Institutional Ownership Invesco Nasdaq Biotechnology ETF Institutional Ownership First Trust Nasdaq Pharmaceuticals ETF Institutional Ownership Direxion Daily Pharmaceutical & Medical Bull 3X Shares Institutional Ownership JPMorgan Healthcare Leaders ETF Institutional Ownership ProShares UltraShort Nasdaq Biotechnology Institutional Ownership ProShares Ultra Nasdaq Biotechnology Institutional Ownership F/m Emerald Life Sciences Innovation ETF Institutional Ownership ProShares Ultra Health Care Institutional Ownership This page (NYSEARCA:BBP) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredGet This Stock NowThis company is the lifeblood of AI data centers, yet almost no one has caught up with the story. Their hardwa...InvestorPlace | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access